ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0918

Retention of variant forms of TNFR1 in the Golgi induces stress responses and monocyte activation in systemic Juvenile Idiopathic Arthritis (sJIA)

Anthony Cruz1, Krisztian Csomos1, Boglarka Ujhazi1, Hiroto Nakano2, Marissa Krantz3, Sophia Chou4, Emily Rosenbaum1, Tianmin Fu5, Dirk Foell6, Rae Yeung7, Pamela Weiss8, Faiza Naz9, Ly-Lan Bergeron1, Michelle Millwood10, Carol Lake11, Emely Verweyen6, Grant Schulert12, Stefania Dell'orso9, Hao Wu13, Zuoming Deng14, davide Randazzo15 and Michael Ombrello16, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD, 2NIAMS, NIH, Bethesda, MD, 3University of Rochester, Bethesda, MD, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Rockville, MD, 5Ohio State University College of Medicine, Columbus, OH, 6University Hospital Muenster, Muenster, Germany, 7The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 8Childrens Hospital of Philadelphia, Philadelphia, PA, 9National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 10National Institutes of Health (NIH), Bethesda, MD, 11NIH, GAITHERSBURG, MD, 12Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 13Harvard University, Cambridge, MA, 14Biodata Mining and Discovery Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 15Light Imaging Section, Office of Science and Technology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, Bethesda, 16National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), North Bethesda, MD

Meeting: ACR Convergence 2025

Keywords: Autoinflammatory diseases, Cell Death, Inflammation, Still's disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0916–0933) Innate Immunity Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic juvenile idiopathic arthritis (sJIA) is severe and poorly understood inflammatory condition. Tumor necrosis factor receptor 1 (TNFR1) is activated by TNF and is found on most cell types. TNFR1 signaling triggers complex formation via its death domain (DD), activating proinflammatory processes through NFκB and various cell death pathways. Using a combination of genetic, in vitro and ex vivo studies, we have discovered a novel class of TNFRSF1A variation in children with sJIA.

Methods: We performed trio exome sequencing in a child with sJIA and targeted sequencing of TNFRSF1A in 525 sJIA cases. TNFR1 DD interactions were examined by modeling, Förster resonance energy transfer (FRET) and immunoprecipitation. TNFR1 variants were assayed in vitro for NFkB and cell death, and receptor localization was analyzed by superresolution microscopy (SRM). Patient peripheral blood mononuclear cells (PBMC) were compared to age matched control PBMC using single cell RNA sequencing (scRNAseq) and SRM. Resting/LPS stimulated monocyte phenotypes, cell death and cytokine secretion were compared to age matched controls ex vivo.

Results: Trio exome sequencing identified a novel, de novo nonsense variant of TNFRSF1A that excludes the transmembrane domain and DD (K203X), while targeted sequencing found 2 subjects with ultra rare variants in the DD (P367S, E398K). All variants showed defective NFκB signaling and attenuated cell death in vitro, attributable to their impaired ability to nucleate the TNFR1 signaling complex, while SRM found reduced surface expression and enhanced Golgi localization of all 3 variants. scRNAseq of K203X PBMC revealed a paucity of classical and nonclassical monocytes. Instead, most monocytes formed a unique patient specific cluster that exhibited suppressed TNF signaling with paradoxical overactivation of NFκB signaling, resulting in a distinct inflammatory signature. Functional enrichment analysis revealed markedly reduced vesicular trafficking and autophagy related pathways, accompanied by activation of stress responses and innate immune pathways. Key regulators of Golgi and endosomal function were consistently downregulated across multiple pathways, indicating widespread disruption of Golgi homeostasis in K203X monocytes. Indeed, K203X PBMC displayed larger areas positive for a Golgi marker, indicative of fragmentation and damage. K203X monocytes also displayed a strongly M1 skewed transcriptional program, adopting a proinflammatory M1 like phenotype and producing abundant inflammatory cytokines even under steady state conditions. Finally, K203X monocytes showed downregulation of cell death related genes and demonstrated striking resistance to apoptosis upon stimulation with LPS or Fas ligand ex vivo, consistent with a hyperinflammatory, antiapoptotic state.

Conclusion: By investigating a novel loss of function variant of TNFR1, we identified a unique mechanism of immune dysregulation. This is characterized by dysfunctional trafficking and chronic accumulation of K203X TNFR1 in the Golgi, which leads to endosomal and autophagic failure, disruption of Golgi homeostasis, and ultimately cascading cellular stress that leads to hyperactive immune function.


Disclosures: A. Cruz: None; K. Csomos: None; B. Ujhazi: None; H. Nakano: None; M. Krantz: None; S. Chou: None; E. Rosenbaum: None; T. Fu: None; D. Foell: None; R. Yeung: AstraZeneca, 5, SOBI, 6; P. Weiss: Bristol-Myers Squibb(BMS), 2, Pfizer, 1; F. Naz: None; L. Bergeron: None; M. Millwood: None; C. Lake: None; E. Verweyen: None; G. Schulert: IpiNovoyx, 5, Novartis, 2, SOBI, 2; S. Dell'orso: None; H. Wu: None; Z. Deng: None; d. Randazzo: None; M. Ombrello: None.

To cite this abstract in AMA style:

Cruz A, Csomos K, Ujhazi B, Nakano H, Krantz M, Chou S, Rosenbaum E, Fu T, Foell D, Yeung R, Weiss P, Naz F, Bergeron L, Millwood M, Lake C, Verweyen E, Schulert G, Dell'orso S, Wu H, Deng Z, Randazzo d, Ombrello M. Retention of variant forms of TNFR1 in the Golgi induces stress responses and monocyte activation in systemic Juvenile Idiopathic Arthritis (sJIA) [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/retention-of-variant-forms-of-tnfr1-in-the-golgi-induces-stress-responses-and-monocyte-activation-in-systemic-juvenile-idiopathic-arthritis-sjia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/retention-of-variant-forms-of-tnfr1-in-the-golgi-induces-stress-responses-and-monocyte-activation-in-systemic-juvenile-idiopathic-arthritis-sjia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology